ACET
Adicet Bio Inc
NASDAQ: ACET · HEALTHCARE · BIOTECHNOLOGY
$7.63
-0.52% today
Updated 2026-04-29
Market cap
$73.22M
P/E ratio
—
P/S ratio
9.72x
EPS (TTM)
$-16.95
Dividend yield
—
52W range
$6 – $17
Volume
0.1M
Adicet Bio Inc (ACET) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-67.50%
ROA
-37.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | $359.59M | $13.47M | 18.72% | 5.94% | 3.75% |
| 2009 | $322.65M | $8.63M | 17.24% | 3.69% | 2.67% |
| 2010 | $346.63M | $6.58M | 15.62% | 2.72% | 1.90% |
| 2011 | $412.43M | $8.97M | 15.96% | 4.01% | 2.17% |
| 2012 | $444.39M | $16.98M | 18.46% | 5.71% | 3.82% |
| 2013 | $499.69M | $22.33M | 19.67% | 6.89% | 4.47% |
| 2014 | $499.69M | $22.33M | 19.67% | 6.89% | 4.47% |
| 2015 | $510.18M | $29.00M | 22.48% | 8.68% | 5.68% |
| 2016 | $546.95M | $-1000.00 | 24.76% | -0.00% | -0.00% |
| 2017 | $558.52M | $-33.78M | 100.00% | -3.38% | -6.05% |
| 2018 | $8.18M | $-9.30M | 99.02% | -182.91% | -113.67% |
| 2019 | $995000.00 | $-28.14M | 100.00% | -3,154.57% | -2,827.94% |
| 2020 | $17.90M | $-36.68M | 100.00% | -218.91% | -204.87% |
| 2021 | $9.73M | $-62.00M | 100.00% | -631.38% | -637.19% |
| 2022 | $24.99M | $-69.79M | 100.00% | -290.32% | -279.27% |
| 2023 | $0.00 | $-142.66M | — | — | — |
| 2024 | $0.00 | $-117.12M | — | — | — |
| 2025 | $0.00 | $-116.80M | — | — | — |